TMX1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.999200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.843600E-01
Normal-vs-Stage2
5.124600E-01
Normal-vs-Stage3
3.820600E-03
Normal-vs-Stage4
8.444600E-01
Stage1-vs-Stage2
5.661400E-01
Stage1-vs-Stage3
2.253600E-01
Stage1-vs-Stage4
5.290400E-01
Stage2-vs-Stage3
1.195510E-03
Stage2-vs-Stage4
6.777200E-01
Stage3-vs-Stage4
2.230600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.878800E-01
Normal-vs-AfricanAmerican
5.710400E-01
Normal-vs-Asian
1.085200E-01
Caucasian-vs-AfricanAmerican
9.779000E-01
Caucasian-vs-Asian
1.426180E-01
AfricanAmerican-vs-Asian
3.650400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.400200E-01
Normal-vs-Female
5.924000E-01
Male-vs-Female
4.520600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.078200E-01
Normal-vs-Age(41-60Yrs)
8.708200E-01
Normal-vs-Age(61-80Yrs)
3.796400E-01
Normal-vs-Age(81-100Yrs)
3.036000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.995600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.198600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.966000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.089580E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.680010E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.857400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.469770E-01
Normal-vs-Daily Drinker
2.301800E-01
Normal-vs-Weekly Drinker
2.532000E-01
Normal-vs-Occasional Drinker
8.287600E-01
Normal-vs-Social Drinker
4.639400E-01
Non Drinker-vs-Daily Drinker
7.690800E-01
Non Drinker-vs-Weekly Drinker
9.406600E-01
Non Drinker-vs-Occasional Drinker
2.064100E-02
Non Drinker-vs-Social Drinker
3.873000E-01
Daily Drinker-vs-Weekly Drinker
7.770400E-01
Daily Drinker-vs-Occasional Drinker
3.800300E-02
Daily Drinker-vs-Social Drinker
5.777600E-01
Weekly Drinker-vs-Occasional Drinker
4.833900E-02
Weekly Drinker-vs-Social Drinker
4.892400E-01
Occasional Drinker-vs-Social Drinker
1.474560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.485400E-01
Normal-vs-Grade 2
2.278600E-01
Normal-vs-Grade 3
1.846560E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.743800E-01
Grade 1-vs-Grade 3
1.393620E-01
Grade 1-vs-Grade 4
4.485400E-01
Grade 2-vs-Grade 3
1.804440E-01
Grade 2-vs-Grade 4
2.278600E-01
Grade 3-vs-Grade 4
1.846560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.020000E-01
Normal-vs-NonDiabetic
4.572800E-01
Diabetic-vs-NonDiabetic
5.257400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.512200E-02
Normal-vs-NoPancreatitis
4.988800E-01
Pancreatitis-vs-NoPancreatitis
1.263820E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.624600E-01
Normal-vs-N1
5.775200E-01
N0-vs-N1
1.693050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.961000E-01
Normal-vs-TP53-NonMutant
4.740800E-01
TP53-Mutant-vs-TP53-NonMutant
8.136400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
